ECCO-the European CanCer Organisation
Trial of new treatment for advanced melanoma shows rapid shrinking of tumors
Published in Medical Device Business Week, October 7th, 2009
In the phase I extension study, researchers have seen rapid and dramatic shrinking of metastatic tumours in patients treated with a new compound that blocks the activity of the cancer-causing mutation of the BRAF gene, which is implicated in about 50% melanomas and 5% of colorectal cancers. In new results from 31 melanoma patients with the BRAF mutation who were treated...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- 3DIcon Corporation
3DIcon Retains Trontz Public Relations as Agency of Record - Aesthetic Plastic Surgery and Laser Center
Farmington Hills Plastic Surgeon Notes More Patients are Recycling or Going Green With Their Own Fat - Ambulatory Surgery
Allied World's Linda McSmith to Speak at Ohio Association of Ambulatory Surgery Centers Annual Meeting - Angiology
Competition in the Peripheral Vascular Stent Market Heating Up - Angiotensins
VisEn Launches ReninSense680 Fast Molecular Imaging Agent to Enable In Vivo Imaging Readouts of Key Biomarkers in Hypertension and Renal Function - Bio Nebraska
Bio Nebraska Partners with Nebraska EPSCoR and University of Nebraska on 5th Annual Research and Innovation Conference in Omaha - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
